Canadian Consortium on Neurodegeneration in Aging (CCNA)
The Canadian Consortium on Neurodegeneration in Aging (CCNA) is a national hub for collaboration research on dementia. CCNA researchers are divided into 19 teams operating at sites located throughout Canada and are working in the areas of prevention, treatment and quality of life.
The University of Waterloo is a research site for one active CCNA study, and all participant visits take place at the Centre for Community, Clinical and Applied Research Excellencce (CCCARE). Here is more information about who can participate and how:
We are currently recruiting participants (at least 60 years of age) for the signature clinical trial of CCNA. Currently being collected at 30 sites across Canada, this is an observational study of people with various types of dementia or cognitive complaints. The study collects clinical, neuropsychological, and MRI imaging data as well as blood, saliva, and urine samples from participants.
- Participants come to CCCARE for 4 study visits over 3 months, including an MRI.
- A telephone check is conducted at 12 months, and baseline procedures are repeated after 2 years.
- More study information is available here: http://ccna-ccnv.ca/compass-nd-study
Synergic (Team 12)
We have recently finished recruiting for this clinical trial. The Synergic trial is studying the combined effects of exercise, cognitive training, and Vitamin D on cognition and mobility of people with mild cognitive impairment.
- Participants must have mild cognitive impairment, be at least 60 years of age, and not currently exercise more than twice a week.
- Participants come to the University of Waterloo three times per week for 5 months.
- There are assessments before 6 months and 1 year after the program.
- More study information is available here: http://synergictrial.com/